Filter By Category
Archives
Share on -
ANAXIRONE
Generic Name: ANAXIRONE
ABSTRACT -
Anaxirone is a synthetic triepoxide alkylating antineoplastic agent evaluated in cancer research. It is designed to damage DNA through epoxide-mediated alkylation, thereby inhibiting DNA synthesis and tumor cell proliferation.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Anaxirone is not an approved routine anticancer therapy.
- Historical oncology trials used protocol-defined intravenous dosing, not suitable for self-use.
- Dose selection requires hematologic and organ-function monitoring.
SIDE EFFECTS–
- Possible side effects include:
- Nausea and vomiting
- Bone marrow suppression
- Mucositis
- Fatigue
- Infection risk
- Bleeding risk
- Hair loss
- Liver or renal laboratory abnormalities
ALLRGIC REACTIONS–
- Possible allergic reaction symptoms include:
- Rash
- Urticaria
- Facial swelling
- Bronchospasm
- Severe hypersensitivity symptoms
- Important: Patients who develop an allergic reaction to Anaxirone should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
- Other myelosuppressive chemotherapy can increase marrow toxicity.
- Radiation therapy may increase mucosal and marrow effects.
- Live vaccines should be avoided in immunosuppressed patients.
- Nephrotoxic or hepatotoxic drugs require caution.
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Use only in authorized research or specialist oncology settings.
- Monitor complete blood counts, liver tests, renal function, and infection signs.
- Avoid pregnancy exposure due to potential genotoxicity.
- Handle as a cytotoxic hazardous drug.
WARNINGS –
- Experimental/discontinued antineoplastic agent; not for routine clinical use.
- Severe myelosuppression and infection can be life-threatening.
- Use protective handling procedures.
- Keep out of reach of children.
Share on -
. Developed by